ChatGPT Outage Disrupts Access for Thousands of Users
OpenAI’s ChatGPT and related services experienced a widespread outage, leaving thousands unable to access the platform. The company is investigating the issue.
Explore the complete archive of AIstify’s news coverage, encompassing all reporting on artificial intelligence across industries, markets, and policy arenas. This archive compiles daily developments, investigative pieces, executive commentary, funding announcements, product launches, and regulatory updates into a single chronological record. It enables readers to track the evolution of AI narratives, corporate strategies, geopolitical shifts, and technological milestones over time.
OpenAI’s ChatGPT and related services experienced a widespread outage, leaving thousands unable to access the platform. The company is investigating the issue.
Adobe has launched CX Enterprise, a new AI platform integrating agents across major tech ecosystems. The move aims to streamline customer experience workflows at scale.
Salesforce has launched Headless 360, exposing its entire platform to AI agents via APIs and tools. The move redefines how enterprise software is accessed and used.
New app releases are surging across the App Store and Google Play, driven by AI tools lowering barriers to development. The trend challenges predictions that AI would replace apps.
Three OpenAI executives have announced their departures, adding to a wave of leadership changes. The exits come as the company restructures teams and prepares for future growth.
Anthropic has introduced Claude Design, a new tool for creating designs, prototypes, and presentations using AI. The product targets both designers and non-designers.
Nvidia has introduced Lyra 2.0, an AI model that generates explorable 3D worlds in real time. It addresses key issues like motion drift and inconsistent object rendering.
Anthropic CEO Dario Amodei is expected to meet White House officials as tensions ease over its Mythos AI model. The talks signal potential renewed government collaboration.
OpenAI has introduced GPT-Rosalind, a specialized AI model for life sciences research. The system aims to accelerate drug discovery and biological analysis workflows.
Researchers at NTU Singapore have developed an AI-powered biochip that detects disease-linked microRNAs in minutes. The system could enable faster, more precise diagnostics.